Contact
searchSearch
HMP Global

Volume 3 - Issue 2 - June 2023

Original Contribution
Tack-Optimized Balloon Angioplasty as a Novel Approach to Dissection Treatment in Below-the-Knee Peripheral Artery Disease: An Exploratory Cost-Effectiveness Analysis
06/06/2023
Khoa Cao, MBBS, MPH, MS; Michael Lichtenberg MD; Ramon L. Varcoe, MBBS, MS, PhD; William A. Gray, MD; Jan B. Pietzsch, PhD
Focal treatment of post-angioplasty dissections in below-the-knee lesions with the novel Tack Endovascular System might provide an attractive treatment approach that contributes clinical benefit at concurrent cost savings at 2-year follow-up....
Focal treatment of post-angioplasty dissections in below-the-knee lesions with the novel Tack Endovascular System might provide an attractive treatment approach that contributes clinical benefit at concurrent cost savings at 2-year follow-up....
Focal treatment of...
06/06/2023
Journal of Critical Limb Ischemia
Editorial/Commentary
Arms Race or Race to the Arm? Obstacles Prevent Widespread Adoption of Transradial Approach for CLTI Interventions
06/11/2023
Constantino S. Peña, MD, FAHA, FSCCT, FSIR
The need for cost-effective, quality care will drive patient treatment decisions and trends. Traditionally, the transfemoral approach has offered a dependable primary access site particularly to approach lower extremity disease. Why should...
The need for cost-effective, quality care will drive patient treatment decisions and trends. Traditionally, the transfemoral approach has offered a dependable primary access site particularly to approach lower extremity disease. Why should...
The need for cost-effective,...
06/11/2023
Journal of Critical Limb Ischemia
Original Contribution
Treatment of Peripheral Artery Disease and Critical Limb Ischemia: An Observational Michigan Medicare Analysis
06/04/2023
Jihad A. Mustapha, MD, FACC, FSCAI; Fadi Saab, MD, FACC, FSCAI; William R. Ranger, MD; Nicolas J. Mouawad, MD, MPH, MBA; Bynthia M. Gates, PhD; Brad J. Martinsen, PhD; Larry J. Diaz-Sandoval, MD; Michael Sumners, DO; Carmen Heaney, BSN; Thomas P. Davis, MD, FACC
The authors completed an observational Michigan Medicare analysis to investigate the rates of peripheral vascular intervention (PVI) via endovascular approach or surgical bypass, as well as the amputation rates for potentially informative...
The authors completed an observational Michigan Medicare analysis to investigate the rates of peripheral vascular intervention (PVI) via endovascular approach or surgical bypass, as well as the amputation rates for potentially informative...
The authors completed an...
06/04/2023
Journal of Critical Limb Ischemia
Original Contribution
Multifactorial Benefits of Transradial Access (TRA) in Endovascular Interventions to Treat Peripheral Arterial Disease — Critical Limb Threatening Ischemia
06/09/2023
Mohammad M. Ansari, MD; Anthony Pham, BS; Cole Pollina, BS; Anthony Bruccoliere, MBA; Geoff Thomas, BS; Ardalan Naghian, BS; Steven Daley, BS; Nitish Mittal, MD; Mikal Ramon, MD; Marina Iskandir, MD; Aliakbar Arvandi, MD; Dixon Santana, MD; Sahil A. Parikh, MD, FACC, FSCAI; Subhash Banerjee, MD; Fadi Saab, MD, FACC, FSCAI; Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
A paradigm shift appears to be occurring with overwhelming evidence of transradial access (TRA) being a safe and feasible approach for peripheral interventions compared to transfemoral access (TFA). Our study explores the additional,...
A paradigm shift appears to be occurring with overwhelming evidence of transradial access (TRA) being a safe and feasible approach for peripheral interventions compared to transfemoral access (TFA). Our study explores the additional,...
A paradigm shift appears to be...
06/09/2023
Journal of Critical Limb Ischemia
Original Contribution
Translesional Assessment of Hemodynamics in Patients Undergoing Endovascular Therapy for Lower Extremity Peripheral Arterial Disease
06/06/2023
Anand Prasad, MD; Marlene Garcia, MD; Ermias Sori, MD; Ghazwan Elias, MD; Badr Harfouch, MD; Christy Luna, BS; Yogamaya Mantha, MD; Anum Asif, MD
The role of real-time, invasive hemodynamic assessment during endovascular therapy for lower extremity peripheral arterial disease (PAD) has not been well established. The purpose of this study was to examine the feasibility of the Navvus...
The role of real-time, invasive hemodynamic assessment during endovascular therapy for lower extremity peripheral arterial disease (PAD) has not been well established. The purpose of this study was to examine the feasibility of the Navvus...
The role of real-time, invasive...
06/06/2023
Journal of Critical Limb Ischemia
Editorial/Commentary
Drug-Eluting Resorbable Scaffolds Below the Knee – Old Dog, New Tricks
06/09/2023
David Barry, MD; William A. Gray, MD
The development of BRS would have the benefit of mechanical support to prevent early vessel recoil and treat dissection similar to BMS and DES, without the permanent metallic struts that would lead to medi- um- and long-term complications...
The development of BRS would have the benefit of mechanical support to prevent early vessel recoil and treat dissection similar to BMS and DES, without the permanent metallic struts that would lead to medi- um- and long-term complications...
The development of BRS would...
06/09/2023
Journal of Critical Limb Ischemia
Editorial/Commentary
Following BEST-CLI and BASIL-2, Do We Better Understand How to “Best” Serve Critical Limb Threatening Ischemia Patients?
06/01/2023
Jos C. van den Berg, MD, PhD; Barry T. Katzen, MD, FACC, FACR, FSIR; Walter Dorigo, MD; Andrew Holden, MBChB; Daniella Kadian-Dodov, MD; Robert A. Lookstein, MD; Jihad A. Mustapha, MD, FACC, FSCAI; John H. Rundback, MD, FAHA, FSIR; Thomas Zeller, MD, PhD
Since there was a striking paucity of high-level comparative effectiveness evidence on the optimal treatment of patients with CLTI so far, both these landmark trials were awaited with great interest. However, study outcomes are conflicting...
Since there was a striking paucity of high-level comparative effectiveness evidence on the optimal treatment of patients with CLTI so far, both these landmark trials were awaited with great interest. However, study outcomes are conflicting...
Since there was a striking...
06/01/2023
Journal of Critical Limb Ischemia
Original Contribution
Translesional Assessment of Hemodynamics in Patients Undergoing Endovascular Therapy for Lower Extremity Peripheral Arterial Disease
06/02/2023
Anand Prasad, MD; Marlene Garcia, MD; Ermias Sori, MD; Ghazwan Elias, MD; Badr Harfouch, MD; Christy Luna, BS; Yogamaya Mantha, MD; Anum Asif, MD
The purpose of this study was to examine the feasibility of the Navvus microcatheter coupled to the RXi system (ACIST Medical Systems) to measure lower extremity pre- and post-intervention resting and hyperemic translesional systolic pressure...
The purpose of this study was to examine the feasibility of the Navvus microcatheter coupled to the RXi system (ACIST Medical Systems) to measure lower extremity pre- and post-intervention resting and hyperemic translesional systolic pressure...
The purpose of this study was to...
06/02/2023
Journal of Critical Limb Ischemia
Editorial/Commentary
Go With the Flow?
06/03/2023
Jos C. van den Berg, MD, PhD
Endovascular treatment of critical limb ischemia has been shown to be effective in preventing amputation and is oftentimes the treatment modality of first choice.
Endovascular treatment of critical limb ischemia has been shown to be effective in preventing amputation and is oftentimes the treatment modality of first choice.
Endovascular treatment of...
06/03/2023
Journal of Critical Limb Ischemia
Editorial/Commentary
Endovascular and Surgical Bypass Therapy: What is the Optimal Strategy to Treat Critical Limb Ischemia?
06/05/2023
Aishwarya Raja, MD; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Although the standard of care has evolved, the majority of patients with CLI undergoing primary amputation have never received a diagnostic angiogram, prohibiting the opportunity for revascularization and limb salvage.
Although the standard of care has evolved, the majority of patients with CLI undergoing primary amputation have never received a diagnostic angiogram, prohibiting the opportunity for revascularization and limb salvage.
Although the standard of care...
06/05/2023
Journal of Critical Limb Ischemia

News

News
Microbot Medical Receives FDA 510(k) Clearance for Its Liberty Endovascular Robotic System
09/08/2025
The FDA has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
The FDA has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
The FDA has granted 510(k)...
09/08/2025
Journal of Critical Limb Ischemia
Dr van den Berg
AMP 2025
Jos van den Berg, MD, PhD, Highlights the Growing Economic Burden of CLTI in Europe
08/14/2025
Jos C. van den Berg, MD, PhD
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional...
08/14/2025
Journal of Critical Limb Ischemia
DR NEVILLE
AMP 2025
Evolving Metrics: Dr Richard Neville Explains How Quality Assessment in CLTI Care Is Being Re-Engineered
08/14/2025
Richard Neville, MD
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines...
08/14/2025
Journal of Critical Limb Ischemia
AMBITION BTK TRIAL FOR CLTI
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
07/24/2025
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective,...
07/24/2025
Vascular Disease Management

Stay in the Know

Journal of Critical Limb Ischemia Newsletter

June 2023 Volume 3 Issue 2

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use